Showing results (311-320 of 426) with videos related to

Sort By:
Pageof 43
JACC. Heart Failure|March 7, 2026
Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCarolyn S P Lam, Biykem Bozkurt, David Z I Cherney, et al.
QJM : Monthly Journal of the Association of Physicians|May 17, 2015
Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysisC Berry, K K Poppe, G D Gamble, et al.
Circulation. Heart Failure|January 22, 2024
Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID TrialJosephine Harrington, Robert J Mentz, Frank W Rockhold, et al.
JACC. Heart Failure|October 11, 2020
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction StudyJustin A Ezekowitz, Christopher M O'Connor, Richard W Troughton, et al.
Circulation. Heart Failure|October 8, 2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA SubstudyPalak Shah, Yinggan Zheng, Burkert Pieske, et al.
Kidney International|March 6, 2026
Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCarolyn S P Lam, Biykem Bozkurt, David Z I Cherney, et al.
Journal of the American College of Cardiology|June 24, 2017
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF TrialStephen J Greene, Adrian F Hernandez, Allison Dunning, et al.
Circulation. Heart Failure|September 15, 2016
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Stephen J Greene, Adrian F Hernandez, Jie-Lena Sun, et al.
Circulation. Heart Failure|March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HFGregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Pageof 43